Insider trades
Senner Christopher J., Director of Quince Therapeutics QNCX, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $4.6M. The latest trade was on 06/11.
Senner Christopher J.
Director
- Company
- Quince Therapeutics QNCX
- First filing
- 23/02/17
- Trades
- 49 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$4.6M
- Last trade
- 06/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ExelixisEXEL | Open-market sale | 05/18 | 05/19 | 34,901 sh | $50.00 | $1,745,050 | −3.5% |
EXEL | Open-market sale | 02/13–02/17 | 02/18 | 64,895 sh2 trades | $43.32avg. | $2,810,998.39 | −6.2% |
ExelixisEXEL | Open-market sale | 25/05/16 | 25/05/16 | 100,000 sh | $46.00 | $4,600,000 | −9.4% |
ExelixisEXEL | Open-market sale | 25/02/24 | 25/02/26 | 29,314 sh | $36.14 | $1,059,407.96 | −3.6% |
ExelixisEXEL | Open-market sale | 24/08/09 | 24/08/09 | 125,000 sh | $27.19 | $3,398,750 | −14.8% |
EXEL | Open-market sale | 23/08/03–23/08/04 | 23/08/07 | 120,000 sh2 trades | $20.60avg. | $2,471,400 | −17.4% |
